Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inf
Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit…
Read the full articleYou might also wanna read
Researchers uncover unexpected role of nitric oxide in urban air pollution and haze formation
scitechdaily.com·41m ago
Multistep HIV vaccine strategy shows promise in primate study by training B cells to produce broadly neutralizing antibodies
cen.acs.org·2h ago
The science of resilience: How adaptive engagement with stress fosters growth
psychologytoday.com·2h agoWHO Regional Director for Africa’s visit to South Africa
iarc.who.int·3h ago
Diagnostic dilemma: An 83-year-old man went to the hospital because of very itchy skin. It turned out he had a rare form of syphilis.
Live Science·4h ago
Long COVID Spending Falls Sharply After Three Months
emjreviews.com·5h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.